The prospects are bright! Amazon sellers received nearly 100 million yuan in financing

In recent years, the demand for medical and health products has continued to increase, and shipments have increased significantly.

According to the latest research data, the global medical device market size has exceeded US$451.7 billion.

Many domestic companies are penetrating into overseas markets by relying on their product strength, ushering in rapid development and gaining favor from the capital market.

Medstar announced the completion of its first round of financing of nearly 100 million yuan

Recently, Medster announced that it has completed its first round of financing of nearly 100 million yuan, with investors including Yuanning Investment, Hengxu Capital and Xiangyu Medical.

It is understood that this round of financing will be mainly used for Medstar's product research and development, supply chain construction and channel expansion, to expand its advantages and competitiveness in the field of home rehabilitation medical devices.

According to public information, Medster was founded in 2013 and is headquartered in Hangzhou. It is mainly engaged in the research and development, production and sales of medical devices and rehabilitation aids.

The company takes "home rehabilitation medical devices" as its core direction, covering four major areas: "rehabilitation nursing, rehabilitation walking assistance, rehabilitation training, and rehabilitation physiotherapy."

Maidester's main products include: medical care bed series, home care bed series, nursing home series, wheelchair series, smart lifting table series, anti-bedsore air mattress series and other health care products.

Currently, the company has nearly 300 SKUs, including electric nursing beds, anti-bedsore mattresses, electric wheelchairs, etc.

It is worth mentioning that Madester has its own intelligent manufacturing factory, covering an area of ​​83 acres. The factory is equipped with fully automatic cutting production lines, fully automatic welding robots, integrated fully automatic spraying lines, etc., and can deliver orders to customers with high standards and high efficiency.

Maidester has established multiple product production lines, with an annual output of 120,000 units (sets) of nursing beds, wheelchairs, and smart anti-bedsore pads.

In 2016, the Maidester brand entered the nursing bed product field on the domestic Tmall and JD e-commerce platforms.

In February 2017, the Medster brand ranked fifth among the best-selling brands of medical devices on Taobao Tmall and was widely recognized by consumers.

At the same time, Maidesite is also actively expanding its overseas markets. Its products are exported to more than 80 countries and regions around the world, and its products have entered companies such as Google, Microsoft, Apple, and Amazon.

In 2019, Madester has held product exhibitions in Dubai, India, Mexico, Thailand, Japan and Germany, and the overseas markets have a very high recognition of Madester's products.

During Amazon Prime Day in 2023, the sales of Maidste exceeded 10 million in two days, an increase of 150% compared with the same period last year. Among them, the export volume of star products in the medical sector of Maidste increased by 264% compared with the same period last year, and the sales of the star product of the lifting table series, maidesite, increased by 145%.

Liu Zhikuo, CEO of Maidester , said that the company's main sales channels are e-commerce and private nursing homes. E-commerce accounts for 55%, and private nursing homes have covered nearly 800. The company's annual revenue growth rate can be maintained at 30% or above, and the company's revenue is expected to reach 400 million yuan this year.

Regarding this round of financing, Liu Zhikuo said that currently Europe and the United States are the company's key overseas markets, and the company plans to establish its own brand DTC overseas, so it needs more financial support. In addition, the current external environment is becoming more complex and severe, and domestic economic development is also facing pressure. If there is capital support, the company will have more room for development.

Medstar’s ability to gain recognition from the market and capital is inseparable from its long-term investment in research and development.

Maidester has an independent R&D team and cooperates with many universities and colleges to carry out product research and development and updates on a daily basis. It focuses on the development of technology, and all products shipped out are verified and tested by the product quality control system.

Medster is trying to explore the technological innovation and application of "digital smart health care" and has already obtained a number of mature patents.

The medical and health equipment track ushers in new development opportunities

In recent years, the global market demand for medical devices has continued to rise and has developed very rapidly.

At present, North America is the world's largest medical device market, accounting for 32% of the global market share. In 2022, the US medical device market size is about 186.5 billion US dollars, and China's medical device exports to the United States are about 21.1 billion US dollars, accounting for 24.9% of China's total medical device exports.

The second largest medical device market is Europe, accounting for 24% of the world. In 2022, the EU medical device market will reach $169.5 billion.

It is estimated that by 2025, the global medical device market size will reach US$766.7 billion.

Especially in the field of home rehabilitation medicine, driven by the needs of emerging consumers, the market size is constantly expanding. In the future, home rehabilitation medical equipment will occupy a larger market share of global medical devices, and Medtronic will also usher in new development opportunities, and capital has also seen the growth potential of this track.

As people pay more attention to health and rehabilitation, the demand for home rehabilitation equipment is also increasing.

In some overseas countries and regions, the government's medical insurance system is also expanding its coverage of home rehabilitation equipment, and in the future, more patients will be able to obtain home rehabilitation equipment through medical insurance. On another level, it can promote the increase in market demand.

Against the backdrop of the rapidly developing home rehabilitation medical market, Medtronic's completion of this round of financing will help promote the company's future development.

As a leading company in this field, Medstar can fully meet the diverse needs of consumers.

In the medical device sector, another well-known overseas company is Mindray Medical.

Mindray Medical was founded in 1991 and is headquartered in Shenzhen. Its main businesses can be divided into three major sectors: life information and support, in vitro diagnostics, and medical imaging.

As early as 2000, Mindray Medical began to try to do international business.

In 2006, Mindray Medical was listed on the NASDAQ in the United States, and it was also the first Chinese medical company to be listed on the New York Stock Exchange.

In March 2016, the company was privatized and delisted from the U.S. stock market with a market value of US$3.3 billion.

In 2018, Mindray Medical was listed on the A-share market.

In recent years, Mindray Medical's revenue and net profit have maintained a rapid growth trend.

In 2022, Mindray Medical's total operating revenue reached 30.366 billion yuan, an increase of 20.17% over the same period last year; total profit was 10.94 billion yuan, an increase of 21.48% over the same period last year; net profit was 9.611 billion yuan, an increase of 20.07% over the same period last year.

Recently, Mindray Medical released its 2023 semi-annual report. According to the financial report data, from January to June 2023, the company achieved operating income of 18.476 billion yuan, a year-on-year increase of 20.32%; and achieved a net profit attributable to shareholders of 6.442 billion yuan, a year-on-year increase of 21.83%.

As for the reasons for the rapid growth in performance, Mindray Medical stated that thanks to the development of new domestic medical infrastructure and breakthroughs in overseas high-end customer groups, the company's performance has grown rapidly, with the growth rate significantly accelerating compared with the previous year.

In general, the development momentum of global medical devices is positive. Sellers who want to enter the market can seize the current development opportunities.

Financing

Amazon Sellers